We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
+6.41%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$258M
AUM Growth
+$58.7M
(+29%)
Cap. Flow
+$51.8M
Cap. Flow
% of AUM
20.06%
Top 10 Holdings %
Top 10 Hldgs %
5.27%
Holding
912
New
322
Increased
209
Reduced
112
Closed
269
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nordson
NDSN
|
+$1.37M |
| 2 |
Hillman Solutions
HLMN
|
+$1.35M |
| 3 |
US Bancorp
USB
|
+$1.34M |
| 4 |
UMH
UMH Properties
UMH
|
+$1.15M |
| 5 |
Independence Realty Trust
IRT
|
+$1.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadridge
BR
|
+$1.47M |
| 2 |
Caterpillar
CAT
|
+$1.15M |
| 3 |
Sonos
SONO
|
+$1.13M |
| 4 |
Gartner
IT
|
+$837K |
| 5 |
HI
Hillenbrand
HI
|
+$793K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.72% |
| 2 | Industrials | 17.32% |
| 3 | Technology | 12.65% |
| 4 | Healthcare | 10.6% |
| 5 | Consumer Discretionary | 10.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Brookdale Senior Living
BKD
$3.62B
| $137K | 0.05% |
+16,136
| New | +$123K |
|
602
Arhaus
ARHS
$1.12B
| $136K | 0.05% |
12,748
+991
| +8% | +$10.4K |
|
603
Gossamer Bio
GOSS
$66.5M
| $135K | 0.05% |
+51,264
| New | +$113K |
|
604
GoodRx Holdings
GDRX
$1B
| $133K | 0.05% |
31,425
-46,382
| -60% | -$204K |
|
605
Arbutus Biopharma
ABUS
$865M
| $131K | 0.05% |
28,864
-32,241
| -53% | -$118K |
|
606
Mama's Creations
MAMA
$825M
| $131K | 0.05% |
12,432
-16,518
| -57% | -$150K |
|
607
Organon & Co
OGN
$3.55B
| $127K | 0.05% |
11,921
+926
| +8% | +$9.09K |
|
608
Ribbon Communications
RBBN
$354M
| $123K | 0.05% |
+32,323
| New | +$127K |
|
609
LSB Industries
LXU
$881M
| $123K | 0.05% |
15,576
-61,738
| -80% | -$501K |
|
610
Akebia Therapeutics
AKBA
$327M
| $121K | 0.05% |
44,451
+3,455
| +8% | +$11.5K |
|
611
VTEX
VTEX
$665M
| $117K | 0.05% |
26,688
-3,484
| -12% | -$17.6K |
|
612
AdaptHealth
AHCO
$1.46B
| $114K | 0.04% |
+12,777
| New | +$118K |
|
|
NNDM
613
Nano Dimension
NNDM
$309M
| $108K | 0.04% |
68,863
-58,096
| -46% | -$84.7K |
|
614
Immersion
IMMR
$216M
| $108K | 0.04% |
14,694
+1,142
| +8% | +$8.28K |
|
|
LUXE
615
LuxExperience B.V.
LUXE
$1.1B
| $107K | 0.04% |
+12,577
| New | +$105K |
|
616
Nomura Holdings
NMR
$28.7B
| $107K | 0.04% |
14,705
+1,143
| +8% | +$8.03K |
|
|
ATXS
617
DELISTED
Astria Therapeutics
ATXS
| $106K | 0.04% |
14,569
-18,806
| -56% | -$127K |
|
618
Ardelyx
ARDX
$1.24B
| $103K | 0.04% |
18,653
-76,460
| -80% | -$415K |
|
619
SelectQuote
SLQT
$114M
| $101K | 0.04% |
51,456
-35,955
| -41% | -$76.1K |
|
620
Advantage Solutions
ADV
$484M
| $101K | 0.04% |
+2,628
| New | +$109K |
|
621
Unisys
UIS
$227M
| $100K | 0.04% |
25,705
+1,998
| +8% | +$8.1K |
|
622
Blend Labs
BLND
$409M
| $96.5K | 0.04% |
26,436
-43,715
| -62% | -$157K |
|
623
Candel Therapeutics
CADL
$700M
| $95.3K | 0.04% |
18,696
+1,453
| +8% | +$8.4K |
|
624
Grab
GRAB
$13.5B
| $95.1K | 0.04% |
15,795
+1,228
| +8% | +$6.52K |
|
625
MiMedx Group
MDXG
$626M
| $94.2K | 0.04% |
+13,498
| New | +$93.8K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q3 2025 Portfolio in Review
As of Q3 2025, EntryPoint Capital held 912 positions worth $258M, up 29% from $200M the previous quarter. Its ten largest holdings account for 5.3% of the portfolio.
EntryPoint Capital deployed $51.8M of net new capital in Q3 2025, opening 322 new positions and adding to 209 existing holdings. Its largest new stake was Nordson: 6,227 shares worth $1.41M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 16% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Sonos, an estimated $1.13M trimmed.
- EntryPoint Capital's largest Q3 2025 buy was Nordson: 6,227 shares worth $1.41M.
- EntryPoint Capital added most to UMH Properties in Q3 2025, an estimated $1.15M increase.
- EntryPoint Capital's biggest Q3 2025 reduction was Sonos, cutting an estimated $1.13M.
- EntryPoint Capital fully exited Broadridge in Q3 2025, selling an estimated $1.47M.
- EntryPoint Capital's ten largest holdings make up 5.3% of its $258M portfolio in Q3 2025.
- EntryPoint Capital opened 322 new positions and closed 269 in Q3 2025.
- EntryPoint Capital's portfolio value rose 29% quarter-over-quarter to $258M.
Based on EntryPoint Capital's 13F filing for Q3 2025, filed 13 Nov 2025.